Canine Influenza Vaccine Market
Global Canine influenza vaccine Market Size, Share & Trends Analysis Report by Type (Powder and Dry), and by End-User (Home, Pet Clinic and Others) Forecast 2022-2028 Update Available - Forecast 2024-2030
The global Canine influenza vaccine market is projected to reach at a considerable CAGR of 4.9% during the forecast period. Canine influenza is also referred to as canine flu. It is found in canines. This type of influenza is caused by a variety of influenza A viruses, the most common of which is the equine influenza virus. It spreads via aerosols or droplets produced by sneezing, barking, and coughing in dogs. It happens when a healthy dog comes into contact with an infected one. The increasing prevalence of canine influenza in developed countries is a major driver of market growth.For instance, in February 2022, the World Health Organization (WHO) has released recommendations for the viral composition of influenza vaccines for the northern hemisphere's 2022-2023 influenza season. The announcement was made at the conclusion of a four-day Information Meeting on Influenza Virus Vaccines. In addition, new product launches by pharmaceutical companies and players operating in the market has also increased the market growth in recent years. For instance, Vanguard® CIV H3N2/H3N8 was introduced by Zoetis in 2017. The bivalent vaccine helps protect dogs against two strains of the virus known to be circulating in the U.S., CIV H3N2 and CIV H3N8.
Impact of COVID-19 Pandemic on Global Canine Influenza Vaccine Market
The COVID-19 pandemic has impacted the global economy due to a slowdown in the manufacturing of various industries. However, this industry has been turned upside down by the pandemic, which has resulted in an unprecedented increase in demand and an acute supply shortage. The demand for canine influenza vaccine were constant there were no significant changes had been seen. As there were no evidence that any animal or pet can infect humans with the coronavirus.
Segmental Outlook
The global canine influenza vaccine market is segmented based on the type, and end-users. Based on the type, the market is segmented into powder and dry. Based on end-users the market is sub-segmented into home, pet clinics, and others. Among these, the end-users segment is anticipated to propel the growth of the market over the forecast period, owing to the rising prevalence of this disease among dogs living in shelters, daycare centers, and kennels.
Global Canine Influenza Vaccine Market Share by End-User, 2020 (%)
The End-User Segment is Anticipated to Hold a Prominent Share in the Global Canine influenza vaccine Market
The growing prevalence of canine influenza in developed countries has increased demand for the canine influenza vaccine. Due to increasing dog ownership in emerging economies as they are considered as best companions, the demand for canine vaccine is also increasing. Pet owners especially dog owners are keener towards their dog healthcare and due which they visit regularly to pet clinics for required check-ups. Furthermore, the key players' new launches of canine flu vaccines are expected to drive market growth. For instance, Vanguard CIV H3N2/H3N8, the latest vaccine in Zoetis' canine influenza virus (CIV) portfolio, has been launched. The vaccine recall could be a hindrance to market growth.
Regional Outlooks
The global ocular implant market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). .
Global Canine influenza vaccine Market Growth, by Region 2022-2028
The Asia-Pacific Region is estimated to Hold the Major Share in the Global Canine influenza vaccine Market
The Asia-Pacific is anticipated to hold a prominent share in the market during the forecast period. The increasing dog ownership and significant investment on dogs healthcare driving the market growth in region. Moreover, demand for treatments and investments in establishment of new manufacturing facilities are further bolstering the overall market growth. The lower cost of the procedure as compared to other alternative treatments and low risk associated with the procedure is expected to increase the market for canine influenza vaccine during the forecast period.
Market Players Outlook
The major companies serving the global canine influenza vaccine market include Bristol-Myers Squibb Co., Boehringer Ingelheim Int. GmbH, Eli Lilly & Co., GlaxoSmithKline Plc., Novartis AG, Pfizer Inc., Sanofi, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Zoetis Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market.
The Report Covers
- Market value data analysis of 2022 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global canine influenza vaccine market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Global Canine Influenza Vaccine Market
• Recovery Scenario of Global Canine Influenza Vaccine Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Bristol- Myers Squibb Co.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Boehringer Ingelheim Int. GmbH
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Eli Lilly & Co.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Glaxosmithkline Plc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Novartis AG
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Canine Influenza Vaccine Market by Type
4.1.1. Powder
4.1.2. Dry
4.2. Global Canine Influenza Vaccine Market by End-Users
4.2.1. Home
4.2.2. Pet Clinic
4.2.3. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Novartis AG
6.2. Pfizer Inc.
6.3. Sanofi S.A.
6.4. Abbott Laboratories
6.5. F. Hoffmann-La Roche Ltd.
6.6. CSL Ltd.
6.7. 6 Zoetis Inc.
1. GLOBAL CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL LIQUID CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL POWDER CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
5. GLOBAL CANINE INFLUENZA VACCINE IN HOME MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL CANINE INFLUENZA VACCINE IN PET CLINIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL CANINE INFLUENZA VACCINE IN OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
9. NORTH AMERICAN CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
10. NORTH AMERICAN CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
11. NORTH AMERICAN CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
12. EUROPEAN CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
13. EUROPEAN CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
14. EUROPEAN CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
15. ASIA-PACIFIC CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16. ASIA-PACIFIC CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
17. ASIA-PACIFIC CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
18. REST OF THE WORLD CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. REST OF THE WORLD CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
20. REST OF THE WORLD CANINE INFLUENZA VACCINE MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)?
1. IMPACT OF COVID-19 ON GLOBAL CANINE INFLUENZA VACCINE MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL CANINE INFLUENZA VACCINE MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL CANINE INFLUENZA VACCINE MARKET, 2021-2028 (%)
4. GLOBAL CANINE INFLUENZA VACCINE MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL LIQUID CANINE INFLUENZA VACCINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL POWDERCANINE INFLUENZA VACCINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL CANINE INFLUENZA VACCINE MARKET SHARE BY END-USER , 2021 VS 2028 (%)
8. GLOBAL CANINE INFLUENZA VACCINE IN HOME MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL CANINE INFLUENZA VACCINE IN PET CLINIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL CANINE INFLUENZA VACCINE IN OTHER END-USERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL CANINE INFLUENZA VACCINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. US CANINE INFLUENZA VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
13. CANADA CANINE INFLUENZA VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
14. UK CANINE INFLUENZA VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
15. FRANCE CANINE INFLUENZA VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
16. GERMANY CANINE INFLUENZA VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
17. ITALY CANINE INFLUENZA VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
18. SPAIN CANINE INFLUENZA VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
19. REST OF EUROPE CANINE INFLUENZA VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
20. INDIA CANINE INFLUENZA VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
21. CHINA CANINE INFLUENZA VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
22. JAPAN CANINE INFLUENZA VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
23. SOUTH KOREA CANINE INFLUENZA VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
24. REST OF ASIA-PACIFIC CANINE INFLUENZA VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF THE WORLD CANINE INFLUENZA VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
